269 related articles for article (PubMed ID: 8929723)
1. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
Willems D; Dorchy H; Dufrasne D
Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) in diabetes mellitus.
Ritter MM; Loscar M; Richter WO; Schwandt P
Clin Chim Acta; 1993 Jan; 214(1):45-54. PubMed ID: 8453777
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
Martinez MT; Ramos O; Carretero N; Calvillán M; Gutierrez-López MD; Cuesta P; Serrano-Ríos M
Diabete Metab; 1994; 20(5):454-7. PubMed ID: 7859892
[TBL] [Abstract][Full Text] [Related]
4. [Lp(a) serum concentrations in diabetes mellitus].
Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
[TBL] [Abstract][Full Text] [Related]
5. Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications.
Willems D; Dorchy H; Dufrasne D
Atherosclerosis; 1998 Apr; 137 Suppl():S61-4. PubMed ID: 9694543
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
8. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes.
Pérez A; Carreras G; Caixàs A; Castellví A; Caballero A; Bonet R; Ordóñez-Llanos J; de Leiva A
Diabetes Care; 1998 Sep; 21(9):1517-20. PubMed ID: 9727901
[TBL] [Abstract][Full Text] [Related]
10. [Screening for subclinical complications in children and adolescents with type 1 diabetes: experience acquired in Brussels].
Dorchy H
Rev Med Brux; 2010; 31(2 Suppl):S87-108. PubMed ID: 21812221
[TBL] [Abstract][Full Text] [Related]
11. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
[TBL] [Abstract][Full Text] [Related]
13. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
Rudberg S; Persson B
Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
[TBL] [Abstract][Full Text] [Related]
14. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
[TBL] [Abstract][Full Text] [Related]
15. Screening for subclinical complications in young type 1 diabetic patients: experience acquired in Brussels.
Dorchy H
Pediatr Endocrinol Rev; 2004 Jun; 1(4):380-403. PubMed ID: 16437030
[TBL] [Abstract][Full Text] [Related]
16. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study.
Moosaie F; Firouzabadi FD; Abouhamzeh K; Esteghamati S; Meysamie A; Rabizadeh S; Nakhjavani M; Esteghamati A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1723-1731. PubMed ID: 32636121
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus.
Westerhuis LW; Venekamp WJ
Clin Biochem; 1996 Jun; 29(3):255-9. PubMed ID: 8740512
[TBL] [Abstract][Full Text] [Related]
18. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
[TBL] [Abstract][Full Text] [Related]
19. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
Nordwall M; Hyllienmark L; Ludvigsson J
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
[TBL] [Abstract][Full Text] [Related]
20. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.
Kapelrud H; Bangstad HJ; Dahl-Jørgensen K; Berg K; Hanssen KF
BMJ; 1991 Sep; 303(6804):675-8. PubMed ID: 1833011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
